Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C ; volume:24 ; number:1 ; day:8 ; month:8 ; year:2024 ; pages:1-16 ; date:12.2024
Clinical and experimental medicine ; 24, Heft 1 (8.8.2024), 1-16, 12.2024
- Urheber
-
Abdelaziz, Aya Ismail
Abdelsameea, Eman
Abdel-Samiee, Mohamed
Ghanem, Samar E.
Wahdan, Sara A.
Elsherbiny, Doaa A.
Zakaria, Zeinab
Azab, Samar S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10238-024-01432-x
- URN
-
urn:nbn:de:101:1-2410272131230.494708845574
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abdelaziz, Aya Ismail
- Abdelsameea, Eman
- Abdel-Samiee, Mohamed
- Ghanem, Samar E.
- Wahdan, Sara A.
- Elsherbiny, Doaa A.
- Zakaria, Zeinab
- Azab, Samar S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment